eXagen DIAGNOSTICS, Inc.™ is the leader in the discovery, development, and delivery of genomic tests that are specifically designed to provide physicians and patients with information to better manage cancer and other chronic diseases.
Using powerful proprietary technology, eXagen™ identifies and validates small sets of genomic markers that are used to make practical, meaningful and easy-to-use diagnostic, prognostic and targeted therapy tests for commercial use in clinical laboratories, clinical trials and pharmaceutical development.
